Xiaopeng Lan

1.8k total citations
41 papers, 1.2k citations indexed

About

Xiaopeng Lan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaopeng Lan has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiaopeng Lan's work include Advanced biosensing and bioanalysis techniques (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Xiaopeng Lan is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Xiaopeng Lan collaborates with scholars based in China, United States and Canada. Xiaopeng Lan's co-authors include Kuancan Liu, Xiangyue Yang, Jianwen Que, Baoshun Lin, Meng Zhao, Fei Liu, Min Chen, Rui Zhang, Yan Zeng and Kaiyu Wang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaopeng Lan

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopeng Lan China 19 898 234 220 190 161 41 1.2k
Eric A. Klein United States 20 849 0.9× 156 0.7× 296 1.3× 263 1.4× 113 0.7× 38 1.7k
Ge Tao United States 19 1.1k 1.3× 194 0.8× 160 0.7× 126 0.7× 313 1.9× 60 2.0k
Sunjoo Jeong South Korea 26 1.4k 1.6× 352 1.5× 234 1.1× 121 0.6× 61 0.4× 68 1.9k
Tomoaki Niimi Japan 22 703 0.8× 134 0.6× 157 0.7× 117 0.6× 148 0.9× 52 1.4k
Jin G. Park United States 19 808 0.9× 108 0.5× 240 1.1× 200 1.1× 84 0.5× 38 1.3k
Bruna Scaggiante Italy 24 873 1.0× 359 1.5× 238 1.1× 63 0.3× 96 0.6× 66 1.3k
Amanda Del Rosario United States 14 533 0.6× 115 0.5× 189 0.9× 115 0.6× 126 0.8× 23 1.0k
James Pan United States 18 781 0.9× 193 0.8× 284 1.3× 56 0.3× 154 1.0× 35 1.3k
Carmela Dell’Aversana Italy 20 937 1.0× 289 1.2× 172 0.8× 76 0.4× 66 0.4× 40 1.4k
Qixin Leng United States 23 1.2k 1.4× 479 2.0× 459 2.1× 142 0.7× 86 0.5× 49 1.7k

Countries citing papers authored by Xiaopeng Lan

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Lan more than expected).

Fields of papers citing papers by Xiaopeng Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Lan. The network helps show where Xiaopeng Lan may publish in the future.

Co-authorship network of co-authors of Xiaopeng Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopeng Lan. A scholar is included among the top collaborators of Xiaopeng Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopeng Lan. Xiaopeng Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Xinyan, Jinghua Shi, Fei Zou, et al.. (2024). Omics detection and treatment of syphilis. Clinica Chimica Acta. 565. 120008–120008. 2 indexed citations
3.
Li, Yumeng, Xinyan Shi, Wei Yang, et al.. (2024). Network pharmacology analysis revealed the mechanism and active compounds of jiao tai wan in the treatment of type 2 diabetes mellitus via SRC/PI3K/AKT signaling. Journal of Ethnopharmacology. 337(Pt 2). 118898–118898. 10 indexed citations
4.
Li, Pei, et al.. (2023). Research and practice of the BOPPPS teaching model based on the OBE concept in clinical basic laboratory experiment teaching. BMC Medical Education. 23(1). 882–882. 16 indexed citations
5.
Zhao, Meng, Weibin Li, Kuancan Liu, Huiling Li, & Xiaopeng Lan. (2019). C4-HSL aptamers for blocking qurom sensing and inhibiting biofilm formation in Pseudomonas aeruginosa and its structure prediction and analysis. PLoS ONE. 14(2). e0212041–e0212041. 16 indexed citations
6.
Yan, Huihui, Kaiyu Wang, Qiang Wang, et al.. (2019). Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials. Journal of Translational Medicine. 17(1). 204–204. 7 indexed citations
7.
Chen, Xin, Xiaosong Liu, Bin Deng, et al.. (2018). Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis. Scientific Reports. 8(1). 16867–16867. 6 indexed citations
8.
Wei, Muyun, Guo‐Liang Lu, Li Liang, et al.. (2018). Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. BMC Cancer. 18(1). 434–434. 26 indexed citations
9.
Liao, Jian, Kaiyu Wang, Weirong Yao, et al.. (2017). Cloning, expression and antioxidant activity of a thioredoxin peroxidase from Branchiostoma belcheri tsingtaunese. PLoS ONE. 12(4). e0175162–e0175162. 5 indexed citations
10.
Liu, Kuancan, Rui Zhang, Long Zhang, et al.. (2017). SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Molecular Cancer. 16(1). 62–62. 85 indexed citations
11.
Lu, Guo‐Liang, Xiaopeng Lan, Wei Jiang, et al.. (2017). Valproic acid inhibits epithelial-mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression. Molecular Medicine Reports. 16(5). 6190–6199. 12 indexed citations
12.
Wang, Kaiyu, Dong Wu, Zhuang Chen, et al.. (2016). Inhibition of the superantigenic activities of Staphylococcal enterotoxin A by an aptamer antagonist. Toxicon. 119. 21–27. 20 indexed citations
13.
Lin, Baoshun, Rui Zhang, Hongyu Ma, et al.. (2015). Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A. Medicine. 94(31). e1301–e1301. 11 indexed citations
14.
Lan, Xiaopeng, Guo‐Liang Lu, Wei Jiang, et al.. (2015). Valproic acid (VPA) inhibits the epithelial–mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. Journal of Cancer Research and Clinical Oncology. 142(1). 177–185. 37 indexed citations
15.
Li, Jieping, et al.. (2015). Repression of PES1 expression inhibits growth of gastric cancer. Tumor Biology. 37(3). 3043–3049. 15 indexed citations
16.
Lan, Xiaopeng, Yougen Chen, Zheng Wang, et al.. (2015). Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients. Journal of Zhejiang University SCIENCE B. 16(9). 743–756. 14 indexed citations
17.
Liu, Kuancan, Baoshun Lin, Meng Zhao, et al.. (2013). The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cellular Signalling. 25(5). 1264–1271. 217 indexed citations
18.
Wang, Kaiyu, Baoshun Lin, Jianmin Lin, & Xiaopeng Lan. (2012). A novel mutation in the myeloperoxidase gene in a Chinese female with complete myeloperoxidase deficiency: The role of nonsense-mediated mRNA decay. Gene. 515(1). 205–207. 1 indexed citations
19.
Zheng, Chengjian, Xiaopeng Lan, Yang Wang, et al.. (2012). A new labdane diterpene fromVitex negundo. Pharmaceutical Biology. 50(6). 687–690. 17 indexed citations
20.
Liu, Kuancan, Baoshun Lin, & Xiaopeng Lan. (2012). Aptamers: A promising tool for cancer imaging, diagnosis, and therapy. Journal of Cellular Biochemistry. 114(2). 250–255. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026